Global Radiopharmaceutical Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Radiopharmaceutical market size will reach 7,858.17 Million USD in 2025 and is projected to reach 13,182.09 Million USD by 2032, with a CAGR of 7.67% (2025-2032). Notably, the China Radiopharmaceutical market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A radiopharmaceutical is a medicinal compound that contains a radioactive isotope and is used in nuclear medicine for diagnostic or therapeutic purposes. These compounds are designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected using specialized imaging equipment, providing valuable information about the structure and function of organs or tissues. In therapeutic applications, the radioactive emissions from the radiopharmaceutical are used to deliver targeted radiation to diseased cells, such as in the treatment of certain types of cancer. Radiopharmaceuticals undergo rigorous testing and regulatory approval processes to ensure their safety and efficacy in medical applications.
The major global suppliers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Radiopharmaceutical. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Radiopharmaceutical market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Radiopharmaceutical market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Radiopharmaceutical industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Radiopharmaceutical Include:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Radiopharmaceutical Product Segment Include:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Radiopharmaceutical Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Radiopharmaceutical Industry PESTEL Analysis
Chapter 3: Global Radiopharmaceutical Industry Porter's Five Forces Analysis
Chapter 4: Global Radiopharmaceutical Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Radiopharmaceutical Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Radiopharmaceutical Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Radiopharmaceutical Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Radiopharmaceutical market size will reach 7,858.17 Million USD in 2025 and is projected to reach 13,182.09 Million USD by 2032, with a CAGR of 7.67% (2025-2032). Notably, the China Radiopharmaceutical market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A radiopharmaceutical is a medicinal compound that contains a radioactive isotope and is used in nuclear medicine for diagnostic or therapeutic purposes. These compounds are designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected using specialized imaging equipment, providing valuable information about the structure and function of organs or tissues. In therapeutic applications, the radioactive emissions from the radiopharmaceutical are used to deliver targeted radiation to diseased cells, such as in the treatment of certain types of cancer. Radiopharmaceuticals undergo rigorous testing and regulatory approval processes to ensure their safety and efficacy in medical applications.
The major global suppliers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Radiopharmaceutical. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Radiopharmaceutical market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Radiopharmaceutical market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Radiopharmaceutical industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Radiopharmaceutical Include:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Radiopharmaceutical Product Segment Include:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Radiopharmaceutical Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Radiopharmaceutical Industry PESTEL Analysis
Chapter 3: Global Radiopharmaceutical Industry Porter's Five Forces Analysis
Chapter 4: Global Radiopharmaceutical Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Radiopharmaceutical Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Radiopharmaceutical Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Radiopharmaceutical Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Radiopharmaceutical Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Radiopharmaceutical Product by Type
- 1.2.1 Actinium-225
- 1.2.2 Lutetium-177
- 1.2.3 Radium-223
- 1.2.4 Holmium-166
- 1.2.5 Other
- 1.3 Radiopharmaceutical Product by Application
- 1.3.1 Oncology
- 1.3.2 Cardiology
- 1.3.3 Other
- 1.4 Global Radiopharmaceutical Market Size Analysis (2020-2032)
- 1.5 Radiopharmaceutical Market Development Status and Trends
- 1.5.1 Radiopharmaceutical Industry Development Status Analysis
- 1.5.2 Radiopharmaceutical Industry Development Trends Analysis
- 2 Radiopharmaceutical Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Radiopharmaceutical Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Radiopharmaceutical Market Analysis by Country
- 4.1 Global Radiopharmaceutical Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Radiopharmaceutical Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Radiopharmaceutical Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.5 China Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.6 France Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.14 India Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Radiopharmaceutical Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Radiopharmaceutical Market Revenue by Key Suppliers (2021-2025)
- 5.2 Radiopharmaceutical Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Radiopharmaceutical Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Radiopharmaceutical Market Analysis by Type
- 6.1 Global Radiopharmaceutical Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Radiopharmaceutical Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Bracco Imaging
- 7.1.1 Bracco Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Bracco Imaging Radiopharmaceutical Product Portfolio
- 7.1.3 Bracco Imaging Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Bayer
- 7.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Bayer Radiopharmaceutical Product Portfolio
- 7.2.3 Bayer Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Mallinckrodt
- 7.3.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Mallinckrodt Radiopharmaceutical Product Portfolio
- 7.3.3 Mallinckrodt Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Nordion
- 7.4.1 Nordion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Nordion Radiopharmaceutical Product Portfolio
- 7.4.3 Nordion Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Triad Isotopes
- 7.5.1 Triad Isotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Triad Isotopes Radiopharmaceutical Product Portfolio
- 7.5.3 Triad Isotopes Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Lantheus
- 7.6.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Lantheus Radiopharmaceutical Product Portfolio
- 7.6.3 Lantheus Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 IBA Group
- 7.7.1 IBA Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 IBA Group Radiopharmaceutical Product Portfolio
- 7.7.3 IBA Group Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 GE Healthcare
- 7.8.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 GE Healthcare Radiopharmaceutical Product Portfolio
- 7.8.3 GE Healthcare Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 China Isotope & Radiation
- 7.9.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 China Isotope & Radiation Radiopharmaceutical Product Portfolio
- 7.9.3 China Isotope & Radiation Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Jubilant Pharma
- 7.10.1 Jubilant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Jubilant Pharma Radiopharmaceutical Product Portfolio
- 7.10.3 Jubilant Pharma Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Eli Lilly
- 7.11.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Eli Lilly Radiopharmaceutical Product Portfolio
- 7.11.3 Eli Lilly Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Advanced Accelerator Applications
- 7.12.1 Advanced Accelerator Applications Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
- 7.12.3 Advanced Accelerator Applications Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 SIEMENS
- 7.13.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 SIEMENS Radiopharmaceutical Product Portfolio
- 7.13.3 SIEMENS Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Dongcheng
- 7.14.1 Dongcheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Dongcheng Radiopharmaceutical Product Portfolio
- 7.14.3 Dongcheng Radiopharmaceutical Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Navidea
- 7.15.1
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
